awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34560277-8E4314AF-141A-4955-BA92-65F5622A3862
Q34560277-8E4314AF-141A-4955-BA92-65F5622A3862
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34560277-8E4314AF-141A-4955-BA92-65F5622A3862
Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.
P2860
Q34560277-8E4314AF-141A-4955-BA92-65F5622A3862
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34560277-8E4314AF-141A-4955-BA92-65F5622A3862
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ea9b0fda61905fdf116f6d82f3cea88c9e4819e7
P2860
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.